Document Detail


Intravenous alpha-1-antitrypsin replacement therapy: case report after one year of treatment.
MedLine Citation:
PMID:  9057422     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Alpha-1-antitrypsin deficiency is an autosomally inherited disease in which individuals homozygous for the disorder are prone to develop severe emphysema. We report the case of a 43 yr old man with severe deficiency and advanced emphysema and the first experience in Ireland with intravenous alpha-1-antitrypsin replacement. After 1 yr of replacement therapy we report our experience with dosage and frequency of infusion as well as pulmonary function test data before and during treatment.
Authors:
A C Ward; B A Keogh
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Irish journal of medical science     Volume:  166     ISSN:  0021-1265     ISO Abbreviation:  Ir J Med Sci     Publication Date:    1997 Jan-Mar
Date Detail:
Created Date:  1997-04-14     Completed Date:  1997-04-14     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7806864     Medline TA:  Ir J Med Sci     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  7-9     Citation Subset:  IM    
Affiliation:
Mater Misericordiae Hospital, Dublin.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Drug Administration Schedule
Follow-Up Studies
Humans
Ireland
Male
Pulmonary Emphysema / drug therapy*,  etiology
Respiratory Function Tests
Serine Proteinase Inhibitors / administration & dosage,  therapeutic use*
alpha 1-Antitrypsin / administration & dosage,  therapeutic use*
Chemical
Reg. No./Substance:
0/Serine Proteinase Inhibitors; 0/alpha 1-Antitrypsin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The management of first trimester miscarriage by general practitioners in Ireland.
Next Document:  Ethnic differences in the frequency distribution of serum cholinesterase activity.